The bioavailability of a phenytoin granule preparation (“Granule”) was studied in 58 epileptic children, and compared to that of other three phenytoin preparations (“Tablet”, “Powder” and “Powderized Tablet”) under a crossover design.
The S/D ratio of “Granule” was about 1.0 for each age group from 5 to 9 years, and about 1.5 for each age group from 10 to 16 years, with the dosis of 5 mg/kg/day. The difference between two age groups was statistically significant.
The S/D ratios of “Powderized Tablet”, “Tablet” and “Granule” were approximately the same and deli-nitely higher than that of “Powder”. Good correlation was found between the dissolution rate determined in vitro by the paddle method of Japanese Pharmacopoeia and in the S/D ratio in vivo.
The particle size measured by the sieving method suggested that a slightly large particlesize of “Powder” was responsible for its low bioavailability. However, many other factors including wettability, crystal forms, etc, seem to affect the difference of bioavailability considerably.
View full abstract